Flecainide monotherapy is an option for selected patients with catecholaminergic polymorphic ventricular tachycardia intolerant of β-blockade
| Autor: | Thomas M. Roston, Gareth J. Padfield, Arthur A. M. Wilde, Krystien V.V. Lieve, Leenah AlAhmari, Andrew D. Krahn, Shubhayan Sanatani, Tasneem AlAhmari |
|---|---|
| Přispěvatelé: | Cardiology, Graduate School, ACS - Amsterdam Cardiovascular Sciences |
| Rok vydání: | 2015 |
| Předmět: |
Adult
medicine.medical_specialty Medication Therapy Management Treatment outcome Adrenergic beta-Antagonists 030204 cardiovascular system & hematology Catecholaminergic polymorphic ventricular tachycardia β blockade 03 medical and health sciences Electrocardiography 0302 clinical medicine Physiology (medical) Medicine Humans 030212 general & internal medicine Flecainide Voltage-Gated Sodium Channel Blockers Dose-Response Relationship Drug business.industry Drug Substitution Patient Selection Hereditary disorders Drug Tolerance medicine.disease Heart Rhythm Treatment Outcome Family medicine Tachycardia Ventricular Drug Monitoring Cardiology and Cardiovascular Medicine business Anti-Arrhythmia Agents medicine.drug |
| Zdroj: | Heart rhythm, 13(2), 609-613. Elsevier |
| ISSN: | 1556-3871 1547-5271 |
| Popis: | Gareth J. Padfield, MBChB, PhD, Leenah AlAhmari, Krystien V.V. Lieve, MD, Tasneem AlAhmari, Thomas M. Roston, MD, Arthur A. Wilde, MD, PhD, FHRS, Andrew D. Krahn, MD, FHRS, Shubhayan Sanatani, MD, FHRS From Heart Rhythm Services, University of British Columbia, Vancouver, British Columbia, Canada, The Heart Centre, Department of Clinical and Experimental Cardiology, Academic Medical Center, Amsterdam, The Netherlands, and The Princess Al-Jawhara Al-Brahim Centre of Excellence in Research of Hereditary Disorders, King Saud University, Jeddah, Kingdom of Saudi Arabia. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|